124 related articles for article (PubMed ID: 23109690)
1. Imaging follicular lymphoma using positron emission tomography with [(18)F]fluorodeoxyglucose: to what purpose?
Barrington SF; Mikhaeel NG
J Clin Oncol; 2012 Dec; 30(35):4285-7. PubMed ID: 23109690
[No Abstract] [Full Text] [Related]
2. Impact of [(18)F]fluorodeoxyglucose positron emission tomography response evaluation in patients with high-tumor burden follicular lymphoma treated with immunochemotherapy: a prospective study from the Groupe d'Etudes des Lymphomes de l'Adulte and GOELAMS.
Dupuis J; Berriolo-Riedinger A; Julian A; Brice P; Tychyj-Pinel C; Tilly H; Mounier N; Gallamini A; Feugier P; Soubeyran P; Colombat P; Laurent G; Berenger N; Casasnovas RO; Vera P; Paone G; Xerri L; Salles G; Haioun C; Meignan M
J Clin Oncol; 2012 Dec; 30(35):4317-22. PubMed ID: 23109699
[TBL] [Abstract][Full Text] [Related]
3. [Incidental pneumonia on PET imaging].
Cohen F; Chiche L; Rebaudet S; Pegliasco H; Brunel V
Rev Med Interne; 2021 Mar; 42(3):225-226. PubMed ID: 33160705
[No Abstract] [Full Text] [Related]
4. Progressive eyelid and facial swelling due to follicular lymphoma.
Smith LB; Pynnonen MA; Flint A; Adams JL; Elner VM
Arch Ophthalmol; 2009 Aug; 127(8):1068-70. PubMed ID: 19667354
[No Abstract] [Full Text] [Related]
5. No convincing evidence to support postinduction FDG-PET in follicular lymphoma.
Adams HJ; Kwee TC
Ann Hematol; 2016 Dec; 95(12):2085-2086. PubMed ID: 27604230
[No Abstract] [Full Text] [Related]
6. [Follicular lymphoma showing long-term false positive results by FDG-PET after rituximab-containing chemotherapy].
Miyazaki Y; Nawa Y; Kohashi S; Nakase K; Miyagawa M; Hara M
Rinsho Ketsueki; 2012 Feb; 53(2):252-4. PubMed ID: 22450588
[TBL] [Abstract][Full Text] [Related]
7. PET for follicular lymphoma: a work in progress!
Wirth A
Leuk Lymphoma; 2007 Aug; 48(8):1463-4. PubMed ID: 17701573
[No Abstract] [Full Text] [Related]
8. Interesting image. Unsuspected synchronous thyroid carcinoma revealed on a post-therapy F-18 FDG PET/CT, in a patient with follicular lymphoma.
Makis W; Hickeson M; Novales-Diaz JA
Clin Nucl Med; 2010 Nov; 35(11):879-81. PubMed ID: 20940548
[No Abstract] [Full Text] [Related]
9. FDG PET-CT in follicular lymphoma: a case-based evidence review.
Smith SD; Redman M; Dunleavy K
Blood; 2015 Feb; 125(7):1078-82. PubMed ID: 25527711
[No Abstract] [Full Text] [Related]
10. End-therapy positron emission tomography for treatment response assessment in follicular lymphoma: a systematic review and meta-analysis.
Pyo J; Won Kim K; Jacene HA; Sakellis CG; Brown JR; Van den Abbeele AD
Clin Cancer Res; 2013 Dec; 19(23):6566-77. PubMed ID: 24052020
[TBL] [Abstract][Full Text] [Related]
11. Primary gastrointestinal follicular lymphoma with histological transformation.
Hangai S; Nakamura F; Kamikubo Y; Ichikawa M; Suzuki H; Yoshida S; Yamada A; Takazawa Y; Fukayama M; Koike K; Kurokawa M
Ann Hematol; 2013 Jul; 92(7):993-4. PubMed ID: 23271213
[No Abstract] [Full Text] [Related]
12. Positron emission tomography response and minimal residual disease impact on progression-free survival in patients with follicular lymphoma. A subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi.
Luminari S; Galimberti S; Versari A; Biasoli I; Anastasia A; Rusconi C; Ferrari A; Petrini M; Manni M; Federico M
Haematologica; 2016 Feb; 101(2):e66-8. PubMed ID: 26471485
[No Abstract] [Full Text] [Related]
13. Positron emission tomography-computed tomography in follicular lymphoma: "one fit for all"?
Luminari S; Trotman J
Leuk Lymphoma; 2015 May; 56(5):1191-2. PubMed ID: 25407656
[No Abstract] [Full Text] [Related]
14. Interim PET in follicular lymphoma: more patience, please.
Procházka V
Ann Hematol; 2023 Jul; 102(7):1953-1954. PubMed ID: 37087410
[No Abstract] [Full Text] [Related]
15. Positron emission tomography-computed tomography (PET-CT) after induction therapy is highly predictive of patient outcome in follicular lymphoma: analysis of PET-CT in a subset of PRIMA trial participants.
Trotman J; Fournier M; Lamy T; Seymour JF; Sonet A; Janikova A; Shpilberg O; Gyan E; Tilly H; Estell J; Forsyth C; Decaudin D; Fabiani B; Gabarre J; Salles B; Van Den Neste E; Canioni D; Garin E; Fulham M; Vander Borght T; Salles G
J Clin Oncol; 2011 Aug; 29(23):3194-200. PubMed ID: 21747087
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of mid- and post-treatment [(18)F]fluorodeoxyglucose (FDG) positron emission tomography (PET) in indolent follicular lymphoma.
Lu Z; Lin M; Downe P; Chong S; Ling S
Ann Nucl Med; 2014 Oct; 28(8):805-11. PubMed ID: 25008291
[TBL] [Abstract][Full Text] [Related]
17. Combined modality treatment for PET-positive non-Hodgkin lymphoma: favorable outcomes of combined modality treatment for patients with non-Hodgkin lymphoma and positive interim or postchemotherapy FDG-PET.
Halasz LM; Jacene HA; Catalano PJ; Van den Abbeele AD; Lacasce A; Mauch PM; Ng AK
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e647-54. PubMed ID: 22607911
[TBL] [Abstract][Full Text] [Related]
18. Reactive follicular lymphoid infiltrate: a new condition to exclude in patients with PET positivity inside the heart.
Di Eusanio M; Nanni C; Zinzani P; Bacci F; Leone O; Lovato L; Castrovinci S; Cefarelli M; Ortolani P; Rapezzi C; Di Bartolomeo R
J Nucl Cardiol; 2014 Apr; 21(2):402-5. PubMed ID: 24235026
[No Abstract] [Full Text] [Related]
19. Combined positron emission tomography/computed tomography imaging of orbital lymphoma.
Chan-Kai BT; Yen MT
Am J Ophthalmol; 2005 Sep; 140(3):531-3. PubMed ID: 16139007
[TBL] [Abstract][Full Text] [Related]
20. Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B-cell non-Hodgkin lymphoma.
Derenzini E; Musuraca G; Fanti S; Stefoni V; Tani M; Alinari L; Venturini F; Gandolfi L; Baccarani M; Zinzani PL
Cancer; 2008 Nov; 113(9):2496-503. PubMed ID: 18833583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
